Skip to main content
. Author manuscript; available in PMC: 2018 Aug 5.
Published in final edited form as: J Pharmacol Sci. 2017 Oct 28;137(2):220–223. doi: 10.1016/j.jphs.2017.10.006

Fig. 1.

Fig. 1

Effects of the sodium glucose co-transporter 2 (SGLT2), TA-1887, on glomerular and tubulointerstitial injuries in non-diabetic 5/6 nephrectomized rats. A, Tubulointerstitium stained with Azan reagents (200× magnification). B, Glomeruli stained with periodic acid-Schiff (PAS) reagents (200× magnification). Neither tubulointerstitial Azan-positive area nor glomerular PAS-positive area differs between vehicle- and TA-1887-treated non-diabetic 5/6 nephrectomized rats.